Militia Capital Partners’s Prelude Therapeutics PRLD Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-4,300	Closed	-$3.3K	–	195
2025 Q1	$3.3K	Hold	4,300	–	–	﹤0.01%	129
2024 Q4	$5.48K	Buy	+4,300	New	+$5.48K	﹤0.01%	188